EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Changes in serological, inflammatory, and serum protein electrophoretic markers during ongoing meglumine antimoniate plus allopurinol therapy in canine leishmaniosis

Jacobo Giner, Ana González, María Eugenia Lebrero, Pablo Quilez, David Guallar, Álex Gómez, Diana Marteles-Aragüés, Sergio Villanueva-Saz

Veterinary Research Communications · 2026-08 · 50 (4)

DOI: 10.1007/s11259-026-11275-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary Research Communications, online erschienen am 16.05.2026. Verfasst von Jacobo Giner und 7 weiteren Autor:innen. Beteiligte Einrichtung: Menescalia Veterinary Clinic, Ismael Merlo Actor, Valencia, Spain. Hauptthemen laut MEDLINE: Meglumine Antimoniate, Allopurinol, Dog Diseases, Antiprotozoal Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad de Zaragoza.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Canine leishmaniosis, caused by Leishmania infantum , is a vector-borne disease in which early treatment monitoring remains challenging. This prospective study evaluated short-term changes in serological, inflammatory, and serum protein electrophoretic parameters during first-line therapy with meglumine antimoniate plus allopurinol. Eighteen dogs with confirmed clinical disease were enrolled at diagnosis, and fifteen dogs completing all follow-up visits (Days 0, 7, 14, 21, and 29) were included. Infection was confirmed by compatible clinical and/or laboratory abnormalities, high anti- Leishmania antibody levels, and successful parasite isolation. Anti- Leishmania antibodies were quantified using in-house single-dilution and two-fold serial dilution ELISA; circulating immune complexes, C-reactive protein, a complete blood count, a biochemical profile, and serum protein electrophoresis were also assessed. Both ELISA methods showed a significant decline in antibody levels during treatment, with serial dilution ELISA showing greater discrimination among highly positive samples. C-reactive protein concentrations decreased significantly from diagnosis to Day 29, indicating reduced systemic inflammation. Serum protein electrophoresis showed significant increases in albumin and the albumin:globulin ratio, along with a significant decrease in gamma globulins. Circulating immune complexes concentrations remained stable. These findings support quantitative serology, C-reactive protein, and serum protein electrophoresis as useful tools for early monitoring of therapeutic response in clinical canine leishmaniosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Meglumine AntimoniateAllopurinolDog DiseasesAntiprotozoal AgentsLeishmaniasis, VisceralLeishmaniasisMeglumineAnimalsDogsFemaleMaleBlood ProteinsLeishmania infantumProspective StudiesBiomarkersC-Reactive ProteinDrug Therapy, CombinationEnzyme-Linked Immunosorbent AssayAntibodies, Protozoan

Stichwörter der Autor:innen

Leishmania infantumCirculating immune complexesDogFollow-upSerologySerum protein electrophoresisTreatment

Substanzen

Meglumine AntimoniateAllopurinolAntiprotozoal AgentsBlood ProteinsBiomarkersC-Reactive ProteinAntibodies, ProtozoanMeglumine

Autor:innen und Institutionen

  • Menescalia Veterinary Clinic, Ismael Merlo Actor, Valencia, Spain.
  • Clinical Immunology Laboratory, Veterinary Faculty, University of Zaragoza, Calle Miguel Servet, 177, Zaragoza, 50013, Spain.
  • Department of Animal Pathology, Veterinary Faculty, University of Zaragoza, Calle Miguel Servet, 177, Zaragoza, 50013, Spain.
  • Instituto Agroalimentario de Aragón-IA2 (Universidad de Zaragoza-CITA), Calle Miguel Servet, 177, Zaragoza, 50013, Spain.
  • Department of Animal Pathology, Veterinary Faculty, University of Zaragoza, Calle Miguel Servet, 177, Zaragoza, 50013, Spain. svs@unizar.es.
  • Clinical Immunology Laboratory, Veterinary Faculty, University of Zaragoza, Calle Miguel Servet, 177, Zaragoza, 50013, Spain. svs@unizar.es.

Förderung

  • Universidad de Zaragoza

Zitieren

APA

Giner, J., González, A., Lebrero, M. E., Quilez, P., Guallar, D., Gómez, Á., Marteles-Aragüés, D., & Villanueva-Saz, S. (2026). Changes in serological, inflammatory, and serum protein electrophoretic markers during ongoing meglumine antimoniate plus allopurinol therapy in canine leishmaniosis. Veterinary Research Communications, 50(4). https://doi.org/10.1007/s11259-026-11275-4

Vancouver

Giner J, González A, Lebrero ME, Quilez P, Guallar D, Gómez Á, et al. Changes in serological, inflammatory, and serum protein electrophoretic markers during ongoing meglumine antimoniate plus allopurinol therapy in canine leishmaniosis. Veterinary Research Communications. 2026;50(4). doi:10.1007/s11259-026-11275-4

BibTeX
@article{Giner2026,
  author = {Giner, Jacobo and González, Ana and Lebrero, María Eugenia and Quilez, Pablo and Guallar, David and Gómez, Álex and Marteles-Aragüés, Diana and Villanueva-Saz, Sergio},
  title = {Changes in serological, inflammatory, and serum protein electrophoretic markers during ongoing meglumine antimoniate plus allopurinol therapy in canine leishmaniosis},
  journal = {Veterinary Research Communications},
  year = {2026},
  volume = {50},
  number = {4},
  doi = {10.1007/s11259-026-11275-4}
}
Kostenlos starten →